BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8607082)

  • 1. Transsphenoidal adenomectomy for microprolactinomas: 10 to 20 years of follow-up.
    Massoud F; Serri O; Hardy J; Somma M; Beauregard H
    Surg Neurol; 1996 Apr; 45(4):341-6. PubMed ID: 8607082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse of hyperprolactinemia after transsphenoidal surgery for microprolactinoma: lessons from long-term follow-up.
    Thomson JA; Gray CE; Teasdale GM
    Neurosurgery; 2002 Jan; 50(1):36-9; discussion 39-40. PubMed ID: 11844232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma.
    Serri O; Rasio E; Beauregard H; Hardy J; Somma M
    N Engl J Med; 1983 Aug; 309(5):280-3. PubMed ID: 6866052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of transsphenoidal selective adenomectomy for prolactinoma.
    Rodman EF; Molitch ME; Post KD; Biller BJ; Reichlin S
    JAMA; 1984 Aug; 252(7):921-4. PubMed ID: 6431121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients.
    Primeau V; Raftopoulos C; Maiter D
    Eur J Endocrinol; 2012 May; 166(5):779-86. PubMed ID: 22301915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Macroadenoma of the pituitary gland with moderate hyperprolactinaemia].
    Harms E; Siggelkow H; Buchfelder M; Saeger W; Hüfner M
    Dtsch Med Wochenschr; 2003 Mar; 128(13):667-70. PubMed ID: 12660899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time Course of Resolution of Hyperprolactinemia After Transsphenoidal Surgery Among Patients Presenting with Pituitary Stalk Compression.
    Zaidi HA; Cote DJ; Castlen JP; Burke WT; Liu YH; Smith TR; Laws ER
    World Neurosurg; 2017 Jan; 97():2-7. PubMed ID: 27671881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transsphenoidal approach to prolactinomas].
    López-Arbolay O; Morales-Sabina O; González-González JL; Valdés-Lorenzo N
    Neurocirugia (Astur); 2006 Jun; 17(3):226-31. PubMed ID: 16855780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: long term follow-up.
    Feigenbaum SL; Downey DE; Wilson CB; Jaffe RB
    J Clin Endocrinol Metab; 1996 May; 81(5):1711-9. PubMed ID: 8626821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microprolactinomas in males treated by transsphenoidal surgery.
    Wolfsberger S; Czech T; Vierhapper H; Benavente R; Knosp E
    Acta Neurochir (Wien); 2003 Nov; 145(11):935-40; discussion 940-1. PubMed ID: 14628197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transsphenoidal microsurgical results of female patients with prolactinomas.
    Ikeda H; Watanabe K; Tominaga T; Yoshimoto T
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1621-5. PubMed ID: 23498159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactinoma surgery.
    Jan M; Dufour H; Brue T; Jaquet P
    Ann Endocrinol (Paris); 2007 Jun; 68(2-3):118-9. PubMed ID: 17512893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of neuronavigation in transnasal transsphenoidal pituitary surgery.
    Thomale UW; Stover JF; Unterberg AW
    Zentralbl Neurochir; 2005 Aug; 66(3):126-32; discussion 132. PubMed ID: 16116555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical management of pituitary adenomas by transsphenoidal approach].
    Liebert W; Szyfter W; Tokarz F; Szmeja Z; Paprzycki W
    Otolaryngol Pol; 1994; 48(3):260-5. PubMed ID: 8090489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery.
    Zielinski G; Ozdarski M; Maksymowicz M; Szamotulska K; Witek P
    Front Endocrinol (Lausanne); 2020; 11():439. PubMed ID: 32733387
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of (68)Ga DOTATATE to 18F-FDG uptake is useful in the differentiation of residual or recurrent pituitary adenoma from the remaining pituitary tissue after transsphenoidal adenomectomy.
    Zhao X; Xiao J; Xing B; Wang R; Zhu Z; Li F
    Clin Nucl Med; 2014 Jul; 39(7):605-8. PubMed ID: 24873787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly.
    Biermasz NR; van Dulken H; Roelfsema F
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4596-602. PubMed ID: 11134114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of female prolactinoma patients at child-bearing age after transsphenoidal surgery.
    Yi N; Ji L; Zhang Q; Zhang S; Liu X; Shou X; Lu B
    Endocrine; 2018 Oct; 62(1):76-82. PubMed ID: 29934876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transsphenoidal microsurgical therapy of prolactinomas: initial outcomes and long-term results.
    Tyrrell JB; Lamborn KR; Hannegan LT; Applebury CB; Wilson CB
    Neurosurgery; 1999 Feb; 44(2):254-61; discussion 261-3. PubMed ID: 9932878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hook effect in prolactin immunoassays.
    Al Sifri SN; Raef H
    Saudi Med J; 2004 May; 25(5):656-9. PubMed ID: 15138537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.